Veronika I. Zarnitsyna

This study compares antibody responses in infants after influenza infection or vaccination, finding greater post-exposure responses following infection compared to vaccination.

This study evaluates antibody responses after a KP.2 spike mRNA vaccine dose, showing durable and broadly cross-reactive immunity against multiple SARS-CoV-2 variants, but reduced neutralizing activity against some emerging subvariants.

The paper identifies TMN CD4+ T cells that persist after YFV vaccination and contribute to long-term immunological memory.

The paper uses mathematical models combined with experimental data to study how inoculum dose affects immune protection and morbidity, finding that an intermediate dose often balances these outcomes best.